Volume 14, Issue 4

Volume 14, Issue 4
17December2019

Letter from the ECCO President

Silvio Danese, ECCO President


Silvio Danese
© ECCO

 

Dear ECCO Friends,

Our annual meeting is just around the corner!

ECCO 2020 in Vienna offers physicians, researchers, nurses and dietitians the opportunity to come together and reflect on our current landscapes in order to align our activities. The meeting will feature plenary sessions, poster sessions and collateral initiatives that merge evidence and experience to empower participants by equipping them with the knowledge and skills needed to provide the best outcomes for patients.

With this purpose in mind, ClinCom is organising several sessions during the upcoming ECCO Congress in Vienna, targeting clinicians, nurses and industry. The 5th Basic ECCO:EduCational COurse for Industry will aim to provide a state of the art introduction to IBD for both corporate and non-corporate members and the 7th ClinCom Workshop will focus on two hot topics in the world of IBD clinical trials.

Posted in ECCO News, Letters from the ECCO President, Volume 14, Issue 4

17December2019

ECCO 1st Council of National Representatives Meeting, held adjacent to UEGW'19

Willem Bemelman, ECCO Secretary

Willem Bemelman
© 
ECCO

On October 19, 2019, ECCO held its 1st Council of National Representatives Meeting adjacent to UEGW Barcelona. The following countries were represented at the meeting: Cyprus, Denmark, Finland, France, Israel, Spain, Italy, Belgium, Bulgaria, Croatia, Estonia, Germany, Greece, Iceland, Latvia, Lithuania, Norway, Poland, Portugal, Romania, Slovenia, the Netherlands, Austria, United Kingdom, Serbia and Sweden.

Topics presented by ECCO Governing Board Officers included the review of relevant results from the Strategic Survey, which had been sent to all ECCO Members at the beginning of the year and to all participants prior to the ECCO 1st Council of National Representatives Meeting. The purpose of the meeting was to deliver information in regard to ECCO Activities and to obtain feedback from the various representatives.

Posted in ECCO News, Volume 14, Issue 4

17December2019

IBD standards and ECCO 2020 Scientific and Educational Programmes

Nuha Yassin, ECCO News Associate Editor

Nuha Yassin
© ECCO

Dear IBD Friends,

Warm greetings to you all at the start of the festive season. As we prepare to welcome the New Year, we are also preparing to welcome you back to our IBD and ECCO hub in the beautiful city of Vienna. Our introduction to ECCO'20 starts slightly differently this time, with a short prelude about IBD standards.

Posted in ECCO News, Committee News, ECCO'20, Volume 14, Issue 4

17December2019

ECCO Grant Study Synopsis: Lissy de Ridder

Lissy de Ridder, ECCO Grant Awardee

Infliximab in Paediatric Crohn’s Disease; in whom to start (ImProve)

 

Lissy de Ridder
© 
Lissy de Ridder

Aim of Research

Crohn’s Disease (CD) is a heterogeneous chronic immune-mediated inflammatory disease. To improve management, precision medicine is urgently needed to target the underlying pathogenic immune response that is driving disease. There is a key unmet need to identify biomarkers that will predict the need for, and the response to, anti-tumor necrosis factor (TNF) treatment, including in paediatric CD. This constitutes the aim of the present project. The use of such predictive biomarkers will help to avoid delay in effective treatment, complications due to ongoing inflammation and exposure of non-responders to anti-TNF. We hypothesise that genetic expression profiling, in combination with thorough patient characterisation, will lead to such biomarkers and thereby improve targeted anti-TNF use in paediatric CD.

Posted in ECCO News, Committee News, SciCom, Fellowships & Grants Synopsis Reports, Volume 14, Issue 4

17December2019

ECCO Grant Study Synopsis: Petra Bacher

Petra Bacher, ECCO Grant Awardee

The immune repertoire of microbe-reactive T cells in blood and tissue of IBD patients

 

Petra Bacher
© 
Petra Bacher

Aim of Research

Dysregulated T cell reactions against intestinal antigens are considered to be a causal or driving factor for Inflammatory Bowel Diseases (IBD). So far, technical limitations concerning the detection and characterisation of microbiota-reactive T cells have prevented determination of the exact contribution of specific T cell subsets against individual microbes to the intestinal balance and its dysregulation in IBD. Analysing the phenotype, function and T cell receptor (TCR) repertoire of microbe-specific T cells in blood and intestinal mucosa of IBD patients will therefore provide important insights to fundamental questions on the clonal expansion of pro- and anti-inflammatory microbe-reactive T cells, their clonal relation and stability and the sites (blood and/ or intestinal tissue) at which the relevant T cell subsets are located.

Posted in ECCO News, Committee News, SciCom, Fellowships & Grants Synopsis Reports, Volume 14, Issue 4

17December2019

ECCO Grant Study Synopsis: Nik Ding

Nik Ding, ECCO Grant Awardee

Sarcopenia as a Predictor of Anti-TNF Non-Response in Crohn’s Disease

 Nik Ding
© 
Nik Ding

Aim of Research

  • To demonstrate that sarcopenia, myopenia and body composition parameters are associated with lower anti-TNF drug levels and primary non-response in patients with moderate to severe Crohn’s Disease who are anti-TNF naive.
  • To demonstrate that sarcopenia is a biomarker of primary non-response (PNR) and secondary loss of response (SLR) to anti-TNF therapy.
  • To demonstrate that sarcopenia/myopenia is a biomarker of primary non-response (PNR) to anti-TNF therapy due to inadequate anti-TNF dosing by use of therapeutic drug monitoring.
  • To demonstrate that improvement of sarcopenia/myopenia increases anti-TNF drug levels and clinical response to anti-TNF drugs.

The hypothesis is that sarcopenia is predictive of low anti-TNF drug levels and possible primary non-response to anti-TNF therapy, and, in addition, that sarcopenia is a predictor for primary non-response and loss of response to anti-TNF therapy which correlates with anti-TNF levels at weeks 4 and 12.

Posted in ECCO News, Committee News, SciCom, Volume 14, Issue 4

17December2019

ECCO Grant Study Synopsis: Carolina Serena

Carolina Serena, ECCO Grant Awardee

An integrative analysis of DNA methylation and RNA-Seq data in human adipose stem cells of Crohn’s Disease patients with different clinical activity

 

Carolina Serena
© 
Carolina Serena

Aim of Research

  1. To identify an epigenetic signature in human adipose stem cells (hASCs) isolated from CD patients with different clinical activity, and to compare this signature with that of hASCs from healthy donors (study of epigenetics).
  2. To explore the effects of DNA methylation on the regulation of gene expression in hASCs isolated from the same cohort (study of transcriptomics).
  3. Integration of data to identify the interplay between differentially methylated DNA sites and the transcriptome profile of hASCs from healthy and CD subjects that could be involved in the dysregulation of hASCs associated with CD.

Posted in ECCO News, Committee News, SciCom, Fellowships & Grants Synopsis Reports, Volume 14, Issue 4

17December2019

ECCO Grant Study Synopsis: Harry Sokol

Harry Sokol, ECCO Grant Awardee

Host–microbiota crosstalk through tryptophan metabolism in Inflammatory Bowel Diseases (IBD)

Harry Sokol
© 
Harry Sokol

Aim of Research

The aim of this work is to study the communication between host cells and microbiota through tryptophan (Trp) metabolism and particularly: (i) the effects of microbes on Trp metabolism in host cells, (ii) the effects of Trp metabolites on host cell response to microbes and (iii) the interaction between epithelial and immune cells through Trp metabolism and the consequences for inflammatory responses.

Posted in ECCO News, Committee News, SciCom, Fellowships & Grants Synopsis Reports, Volume 14, Issue 4

17December2019

ECCO Grant Study Synopsis: Giuseppe D'Agostino

Giuseppe D'Agostino, ECCO Grant Awardee

Brain circuits controlling intestinal inflammation

Giuseppe D'Agostino
© 
Giuseppe D'Agostino

Aim of Research

The caudal brainstem, and particularly the nucleus of the solitary tract (NTS), is of critical importance for pathophysiological signals reaching the brain from the gastrointestinal tract. During inflammation, signals from the gut can be integrated in the NTS to initiate a peripherally directed anti-inflammatory response. However, the neuronal circuits underlying this response are unknown, with no genetic, neurochemical and anatomical information available. This gap in knowledge prevents the development of novel anti-inflammatory strategies. Our team has identified discrete subsets of genetically identified neurons in the NTS that are responsive to microbial and inflammatory stimuli.

Posted in ECCO News, Committee News, SciCom, Fellowships & Grants Synopsis Reports, Volume 14, Issue 4

17December2019

ECCO Grant Study Synopsis: René van den Wijngaard

René van den Wijngaard, ECCO Grant Awardee

Fungal feelings: Abdominal pain during remission

René van den Wijngaard
© 
René van den Wijngaard

Aim of Research

In the absence of ongoing inflammation, a significant proportion of IBD patients in remission continue to suffer from irritable bowel syndrome (IBS)-like symptoms such as pain and diarrhoea (IBD-IBS). Abdominal pain in IBD-IBS is an under-treated problem with a negative impact on quality of life. In IBS, we recently provided evidence that abdominal pain may arise due to immune recognition of an aberrant gut mycobiome. The possible relevance of the gut mycobiome in IBD-IBS has never been studied previously. We aim to perform (1) a descriptive study to establish faecal mycobiome differences when comparing IBD patients in remission with and without IBS complaints and (2) a functional study to show the relevance of the IBD-IBS mycobiome for abdominal pain in a human-to-rat faecal microbiota transfer (FMT) model of post-inflammatory colitis.

Posted in ECCO News, Committee News, SciCom, Fellowships & Grants Synopsis Reports, Volume 14, Issue 4

Portal

We use cookies

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.